Blood Cancer Awareness Month

Each September, Blood Cancer Awareness Month provides an important opportunity to highlight the impact of blood cancers such as leukaemia, lymphoma, and myeloma. It’s a time to support those affected, raise awareness of symptoms, and encourage early diagnosis.

In the UK, blood cancers are among the most common causes of cancer-related deaths. According to Blood Cancer UK, around 41,000 people are diagnosed with a blood cancer every year.
While the NHS provides vital services to detect and treat these conditions, there are times when failures in diagnosis or treatment occur. In some cases, these failures may amount to medical negligence, with serious and sometimes fatal consequences.

Understanding Blood Cancer

Blood cancers develop in the blood, bone marrow, or lymphatic system. The three main types are:

  • Leukaemia – A cancer of the white blood cells and bone marrow.
  • Lymphoma – A cancer of the lymphatic system, including Hodgkin and non-Hodgkin lymphoma.
  • Myeloma – A cancer of plasma cells in the bone marrow.

Common Symptoms

The challenge with blood cancers is that symptoms can be vague and easily mistaken for other illnesses. Some of the key warning signs include (but are not limited to):

  • Persistent fatigue and weakness
  • Unexplained weight loss
  • Night sweats and fevers
  • Frequent infections
  • Unusual bruising or bleeding
  • Swollen lymph nodes

Because these symptoms can be non-specific, early detection relies heavily on the vigilance of GPs and other frontline healthcare professionals.

Early diagnosis significantly improves treatment outcomes for most blood cancers. For instance, the five-year survival rate for some types of Hodgkin lymphoma can exceed 90% when caught early.

Further information and guidance can be found on the Macmillan Cancer Support website: Macmillan’s Cancer Information Blog: Blood Cancer Awareness

Delays in Cancer Diagnosis

However, delays in diagnosis remain a serious issue in the UK. According to Blood Cancer UK, thousands of patients each year experience delays because their symptoms are misattributed to less serious conditions, such as viral infections or stress.

Early recognition often depends on:

  • Timely GP assessments and appropriate investigations.
  • Prompt blood tests
  • Swift referrals to haematology specialists.

Medical negligence occurs when a healthcare provider fails to deliver care to the expected standard, causing harm to the patient. In the context of blood cancer, this can include:

  • Failure to Recognise Symptoms
  • Dismissing or overlooking persistent red-flag symptoms such as unexplained fatigue, bruising, or repeated infections.
  • Delayed or Missed Diagnosis
  • Failing to order basic blood tests or misinterpreting results.
  • Delayed Referrals
  • Not referring a patient to a specialist
  • Treatment Errors
  • Mistakes in administering chemotherapy, stem cell transplants, or other treatments.

Find out more about Blood Cancer UK’s campaign for Blood Cancer Awareness Month: https://bloodcancer.org.uk/about-us/our-campaigns/blood-cancer-awareness-month/

Medical Negligence for Delayed Treatment

When negligence occurs, it can result in delayed treatment, a worsened prognosis, and significant emotional and financial stress for both patients and their families.

If you or a loved one has concerns in relation to the management of blood cancer, please get in touch with one of our understanding medical negligence specialists on 0800 987 8800 or make a free online enquiry and we will contact you. Alternatively, email us at medneg@bmcf.co.uk.

Medical Negligence.co.uk